Sees Q4 system-wide comparable RevPAR, on a currency neutral basis up 4.5%-5.5% compared to the Q4 of 2022; net income $374M-$388M; adjusted EBITDA $739M-$759M.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on HLT: